Scale Biosciences announces ScalePlex technology to simplify single cell genomics studies of any scale

FHS
June 26, 2024
2:16 pm

Novel multiplexing technology enables seamless sample pooling facilitating cost-efficient single cell experiments for compound screening and translational research.

What Coherus’ $40M sale of its Humira biosimilar says about the crowded market

Coherus BioSciences is selling its Humira biosimilar for just $40 million, only three years after it won FDA approval, showing just how crowded the market

June 28, 2024

Summer Health Expands to Primary Care for Parents

What You Should Know: Summer Health, a text-based service for parents to get answers to urgent needs from pediatricians, is expanding into primary care. Improving

November 23, 2023

FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment

ORLYNVAH is indicated for the treatment of uUTIs in adult women. Credit: 9nong/Shutterstock. The US Food and Drug Administration (FDA) has approved Iterum Therapeutics‘ new

October 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.